# Dulaglutide Side Effects: What Studies and Users Report

Source: https://pepvault.app/peptides/dulaglutide/side-effects

Last updated: 2026-10-06

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Dulaglutide](https://pepvault.app/peptides/dulaglutide) Side effects

Peptide questions · Dulaglutide

# Dulaglutide side effects: what studies and users report

Reviewed October 2026 Evidence: Established [Published by PepVault](https://pepvault.app/guides/how-we-research)

The side effects most commonly reported for dulaglutide are nausea, diarrhea and vomiting, among 7 the library lists; the library’s evidence on it includes controlled trials in people.

Its safety note opens: The Trulicity label carries the GLP-1 class boxed warning: dulaglutide caused thyroid C-cell tumors in rats given it for a lifetime, and whether it does so in people is not known, so the label rules it out for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2.

## What is commonly reported with dulaglutide

- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
- Decreased appetite
- Indigestion
- Fatigue

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other metabolic & GLP-1 compounds the library lists it for

| Effect | Also listed for (of 24) |
| --- | --- |
| Nausea | 21: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 17 more |
| Diarrhea | 20: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 16 more |
| Vomiting | 18: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 14 more |
| Abdominal pain | 7: Semaglutide (oral), Tirzepatide, Retatrutide, Setmelanotide and 3 more |
| Decreased appetite | 9: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 5 more |
| Indigestion | 2: Exenatide, Orforglipron |
| Fatigue | 7: Semaglutide, Tirzepatide, Retatrutide, Survodutide and 3 more |

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track dulaglutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Which dulaglutide side effects the metabolic & GLP-1 group shares

Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). Every effect on dulaglutide’s list also appears for at least one other metabolic & GLP-1 compound, so nothing on it is dulaglutide’s own.

## More on dulaglutide

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Studies

- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Ecnoglutide: HbA1c fell up to 1.91% vs 1.65% with dulaglutide](https://pepvault.app/research/ecnoglutide-eecoh-2-2025)
- [All 10 studies](https://pepvault.app/research#dulaglutide)

### Compared with

- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Dulaglutide questions

- [Dulaglutide: half-life](https://pepvault.app/peptides/dulaglutide/half-life)
- [Dulaglutide: how long it takes to work](https://pepvault.app/peptides/dulaglutide/how-long-to-work)

### Terms on this page

- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

## What the dulaglutide safety notes say

> The library’s safety note
>
> The Trulicity label carries the GLP-1 class boxed warning: dulaglutide caused thyroid C-cell tumors in rats given it for a lifetime, and whether it does so in people is not known, so the label rules it out for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Its other warnings are acute pancreatitis (confirmed in 0.2% on 1.5 mg, 0.3% on 3 mg and 0.5% on 4.5 mg in the high-dose trial), low blood sugar when combined with insulin or a sulfonylurea, serious allergic reactions, kidney injury from dehydration after vomiting or diarrhea, severe stomach problems, a temporary worsening of diabetic retinopathy when glucose improves quickly, gallbladder disease, and food reaching the lungs under anesthesia. In the placebo-controlled trials, GI side effects affected 32% on 0.75 mg and 41% on 1.5 mg vs 21% on placebo, mostly mild or moderate, and resting heart rate rose 2 to 4 beats per minute on average. These are label findings; review them with your clinician.

> The library’s interaction note
>
> Dulaglutide slows stomach emptying, most after the first dose, which can slow the absorption of oral medicines: at 1.5 mg it did not change the absorption of the oral drugs tested to a clinically relevant degree, there is little data at 3 and 4.5 mg, and the label suggests monitoring narrow-margin drugs such as warfarin. With insulin or a sulfonylurea, the label suggests considering lower doses of those to limit low blood sugar. It is a GLP-1 drug itself, so it is not stacked with another one. Discuss all your medicines with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

## Where the dulaglutide reports come from

The library rates the evidence on dulaglutide as established: clinical trials or FDA-approved use exist.

Of the library’s 7 research notes on dulaglutide, 6 rest on randomized trials and 1 on community reports.

Our 10 study pages on dulaglutide: 2 animal studies (mice), 7 randomized trials and 1 clinical trial.

So dulaglutide has controlled trials in people to set its listed effects against.

## What our dulaglutide study pages report on safety

### Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c

Randomized trial, human, 2025: At week 40, HbA1c dropped by 1.44% in the tirzepatide arm (15 mg or the highest tolerated dose) and by 0.67% in the dulaglutide arm (4.5 mg or the highest tolerated dose), an estimated difference of -0.77%. Serious side effects happened in 10 (7.2%) people on tirzepatide and 10 (7.0%) on dulaglutide.

- [Read the study page: Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)

### Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks

Randomized trial, human, 2022: Nausea affected 8% of the dulaglutide group and 12% to 20% of the tirzepatide groups; constipation affected 11% versus 14% to 18%. In this Japanese trial, dulaglutide 0.75 mg lowered blood sugar but did little to body weight, and tirzepatide lowered both more, with more nausea.

- [Read the study page: Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks](https://pepvault.app/research/dulaglutide-surpass-j-mono-2022)

### Dulaglutide lowered major cardiovascular events (HR 0.88) in REWIND

Randomized trial, human, 2019: Gut side effects were more common on dulaglutide, reported by 2347 people (47.4%) versus 1687 (34.1%) on placebo. In a large, long trial of older adults with type 2 diabetes, dulaglutide led to fewer major cardiovascular events than placebo, but gut side effects were more common and overall deaths did not clearly differ.

- [Read the study page: Dulaglutide lowered major cardiovascular events (HR 0.88) in REWIND](https://pepvault.app/research/dulaglutide-rewind-2019)

### Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7

Randomized trial, human, 2018: Gut-related side effects were the most common problem: 33% of the dulaglutide 0.75 mg arm and 48% of the dulaglutide 1.5 mg arm, against 43% and 44% with semaglutide, and they were the top reason people stopped either drug. In this head-to-head trial, dulaglutide lowered blood sugar and weight, but less than semaglutide at both dose levels compared, with gut side effects common on both.

- [Read the study page: Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7](https://pepvault.app/research/dulaglutide-sustain-7-2018)

## Questions people ask

### What are the side effects of dulaglutide?

The side effects most commonly reported for dulaglutide are nausea, diarrhea and vomiting, among 7 the library lists; the library’s evidence on it includes controlled trials in people.

### Do dulaglutide’s side effects come from human studies?

The library rates the evidence on dulaglutide as established, and the library’s evidence on it includes controlled trials in people.

### Which dulaglutide side effects are its own?

None: each effect the library lists for dulaglutide is listed for at least one other metabolic & GLP-1 compound too.

### Does dulaglutide interact with other medicines?

The library’s interaction note on dulaglutide begins: dulaglutide slows stomach emptying, most after the first dose, which can slow the absorption of oral medicines: at 1.5 mg it did not change the absorption of the oral drugs tested to a clinically relevant degree, there is little data at 3 and 4.5 mg, and the label suggests monitoring narrow-margin drugs such as warfarin.

## More on dulaglutide

- [Dulaglutide: the full library page](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)
- [Dulaglutide: half-life](https://pepvault.app/peptides/dulaglutide/half-life)
- [Dulaglutide: how long it takes to work](https://pepvault.app/peptides/dulaglutide/how-long-to-work)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track dulaglutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track dulaglutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on dulaglutide

### Dulaglutide

- [Dulaglutide: the full reference](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide dose guide](https://pepvault.app/lab/dosage/dulaglutide)

### Studies

- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Ecnoglutide: HbA1c fell up to 1.91% vs 1.65% with dulaglutide](https://pepvault.app/research/ecnoglutide-eecoh-2-2025)
- [All 10 studies](https://pepvault.app/research#dulaglutide)

### Compared with

- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Dulaglutide questions

- [Dulaglutide: half-life](https://pepvault.app/peptides/dulaglutide/half-life)
- [Dulaglutide: how long it takes to work](https://pepvault.app/peptides/dulaglutide/how-long-to-work)

### Terms on this page

- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Boxed warning](https://pepvault.app/glossary/boxed-warning)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

<!--promo-->

PepVault for iPhone

## Track dulaglutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Dulaglutide

- [Dulaglutide in the library](https://pepvault.app/peptides/dulaglutide)
- [Dulaglutide: half-life](https://pepvault.app/peptides/dulaglutide/half-life)
- [Dulaglutide: how long it takes to work](https://pepvault.app/peptides/dulaglutide/how-long-to-work)

## Tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The peptide glossary](https://pepvault.app/glossary)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
